Showing all 3 results
-
Add to cartSpecification Details Product Name Alluvi Retatrutide 20mg Active Ingredient Retatrutide (LY3437943) Concentration 20mg per vial Mechanism of Action Triple Agonist (GLP-1, GIP, and Glucagon Receptors) Primary Indication Advanced Chronic Weight Management & Metabolic Support Administration Route Subcutaneous Injection Storage Requirements Refrigerate at 2°C to 8°C; protect from direct sunlight -
Add to cart4-16 week supply
A 40mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.
Produced for laboratory research only. Not for human or veterinary consumption.Each Retatrutide 40mg Research kit includes:
Pre-filled Research pen (40mg Retatrutide)
Research information sheet
Storage:
Store refrigerated (2–8°C). Do not freeze.
Supplied in fixed-volume sealed format for laboratory analysis.Delivery: Dispatched with a cold pack.
Tracked 2 DAY UK Delivery.Research & Development purposes only
-
Add to cartSpecification Details Product Name Retatrutide Injection Pen Kit Concentration 40mg Form Type Prefilled Injection Pen Primary Indication Chronic Weight Management & Metabolic Support Mechanism of Action Triple Hormone Receptor Agonist (GIP, GLP-1, Glucagon) Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) Administration Route Subcutaneous Injection